ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,845Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 1448

$1.07M Total Retail Price of All Prescriptions

Rank: 25 out of 1448

873 Patients Receiving at Least One Drug in Part D
97%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

1% of this provider’s 873 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

1% of this provider’s 17,458 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

41% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
AMLODIPINE BESYLATE 1,230 1,227 1 2
PLAVIX 1,222 1,204 10 2 14
CLOPIDOGREL 1,206 1,176 3 10
ATENOLOL 808 800 4 12
ZOLPIDEM TARTRATE 623 606 5 34
NITROSTAT 595 578 10 6 31
SIMVASTATIN 574 561 7 3
LOSARTAN POTASSIUM 573 569 8 11
DIGOXIN 464 447 9 13
FAMOTIDINE 444 429 10 60
DIOVAN 414 412 11 15
CARVEDILOL 396 389 12 1
ISOSORBIDE MONONITRATE ER 380 380 13 16
ATORVASTATIN CALCIUM 375 364 14 4
ALENDRONATE SODIUM 339 339 15 41
BENICAR 278 273 16 50
WELCHOL 251 251 17 103
ISOSORBIDE DINITRATE 232 232 18 63
NEXIUM 217 217 19 49
DONEPEZIL HCL 216 216 20 68
NITROGLYCERIN PATCH 202 202 21 98
OMEPRAZOLE 201 195 22 23
TRIAMCINOLONE ACETONIDE 192 190 23 96
PANTOPRAZOLE SODIUM 190 181 24 42
ACTONEL 184 183 25 117
LOSARTAN-HYDROCHLOROTHIAZIDE 170 170 26 38
METOPROLOL SUCCINATE 170 170 26 6
LOVAZA 168 156 28 39
LIDODERM 155 153 29 81
NIFEDIPINE ER 145 138 30 59
LEVOTHYROXINE SODIUM 141 122 31 21
TAMSULOSIN HCL 137 137 32 46
CLONIDINE HCL 136 120 33 45
CREON 136 136 33 168
METOPROLOL TARTRATE 133 132 35 9
GEMFIBROZIL 128 128 36 127
DILTIAZEM HCL 127 127 37 145
PATANOL 120 117 38 175
DIOVAN HCT 99 99 39 29
VOLTAREN 95 95 40 107
ZETIA 93 93 41 28
WARFARIN SODIUM 92 92 42 8
ALLOPURINOL 90 68 43 43
SOTALOL 88 84 44 40
TERAZOSIN HCL 88 76 44 116
METFORMIN HCL 87 81 46 25
AMIODARONE HCL 85 81 47 22
LIPITOR 84 74 48 30
EVISTA 83 83 49 134
CIPROFLOXACIN HCL 82 80 50 137
PROPRANOLOL HCL 71 71 51 105
CRESTOR 71 71 51 17
NASONEX 68 61 53 155
FUROSEMIDE 67 64 54 7
AVODART 66 55 55 120
GLYBURIDE 61 49 R 56 89
TRIAMTERENE-HYDROCHLOROTHIAZID 58 56 57 156
CELEBREX 52 52 58 77
LEVOFLOXACIN 52 52 58 131
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.